Get started
Author

Eisuke Kurihara

Observed names: E. Kurihara, E., Kurihara, EISUKE KURIHARA, Kurihara, Eisuke
OpenAlex ID: A5000982164
Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR -Mutant Non–Small Cell Lung Cancer Cells
2018 · Kei Namba, Kazuhiko Shien, et al. · Molecular Cancer Research · 89
Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR‐TKIs in non‐small cell lung cancer
2018 · Hiroki Sato, Hiromasa Yamamoto, et al. · Cancer Science · 72
PDF
Newly developed anti‐S100A8/A9 monoclonal antibody efficiently prevents lung tropic cancer metastasis
2018 · Rie Kinoshita, Hiroki Sato, et al. · International Journal of Cancer · 56
PDF
Acquired resistance mechanisms to afatinib in HER 2‐amplified gastric cancer cells
2019 · Takahiro Yoshioka, Kazuhiko Shien, et al. · Cancer Science · 42
Comparative mutational evaluation of multiple lung cancers by multiplex oncogene mutation analysis
2018 · Yuta Takahashi, Kazuhiko Shien, et al. · Cancer Science · 33
PDF
exSSSRs (extracellular S100 soil sensor receptors)‐Fc fusion proteins work as prominent decoys to S100A8/A9‐induced lung tropic cancer metastasis
2018 · Rie Kinoshita, Hiroki Sato, et al. · International Journal of Cancer · 24
PDF
Anti‑tumor effect of neratinib against lung cancer cells harboring HER2 oncogene alterations
2019 · Yusuke Ogoshi, Kazuhiko Shien, et al. · Oncology Letters · 22
PDF
Ganetespib in Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-resistant Non-small Cell Lung Cancer
2019 · EISUKE KURIHARA, KAZUHIKO SHIEN, et al. · Anticancer Research · 12
PDF
Antitumor Effects of Pan-RAF Inhibitor LY3009120 Against Lung Cancer Cells Harboring Oncogenic BRAF Mutation
2020 · SHUNSAKU MIYAUCHI, KAZUHIKO SHIEN, et al. · Anticancer Research · 11
PDF
A case report of a collision tumor composed of pancreatic ductal adenocarcinoma and peri-pancreatic mucosa-associated lymphoid tissue lymphoma
2023 · Ryuji Hirai, Ken-ichi Omae, et al. · World Journal of Surgical Oncology · 3
PDF
[Resection of Chest Wall Metastasis from Rectal Mucinous Carcinoma-A Case Report].
2023 · Kentaro Imanishi, Shuichiro Maruyama, et al. · PubMed · 1
Application of amplicon-based targeted sequencing with the molecular barcoding system to detect uncommon minor EGFR mutations in patients with treatment-naïve lung adenocarcinoma
2019 · Kei Namba, Shuta Tomida, et al. · BMC Cancer · 1
PDF
A case of strangulated ileus caused by internal hernia through a defect in the broad ligament of the uterus
2013 · Minoru Haisa, Ryo Sakai, et al. · Okayama Igakkai Zasshi (Journal of Okayama Medical Association) · 1
PDF
Supplementary Figure legends from Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-Mutant Non–Small Cell Lung Cancer Cells
2023 · Kei Namba, Kazuhiko Shien, et al.
Figure S1-S7 from Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-Mutant Non–Small Cell Lung Cancer Cells
2023 · Kei Namba, Kazuhiko Shien, et al.
PDF
Table S1 from Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-Mutant Non–Small Cell Lung Cancer Cells
2023 · Kei Namba, Kazuhiko Shien, et al.
Figure S1-S7 from Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-Mutant Non–Small Cell Lung Cancer Cells
2023 · Kei Namba, Kazuhiko Shien, et al.
Table S1 from Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-Mutant Non–Small Cell Lung Cancer Cells
2023 · Kei Namba, Kazuhiko Shien, et al.
PDF
Data from Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-Mutant Non–Small Cell Lung Cancer Cells
2023 · Kei Namba, Kazuhiko Shien, et al.
Supplementary Material for: Efficacy and safety of the combination of nano-liposomal irinotecan and 5-fluorouracil/l-leucovorin in unresectable advanced pancreatic cancer: A real-world study
2022 · H., Yasuoka, A., Naganuma, et al. · Figshare
Abstract 2136: Doublecortin-like Kinase 1 (DCLK1) correlates with the cell proliferation in malignant pleural mesothelioma
2019 · Akihiro Miura, Hiromasa Yamamoto, et al. · Cancer Research
Abstract 1410: Clinicopathological characteristics of lung cancer patients with concomitant idiopathic pulmonary fibrosis
2019 · Kota Araki, Kazuhiko Shien, et al. · Clinical Research (Excluding Clinical Trials)
Abstract 2136: Doublecortin-like Kinase 1 (DCLK1) correlates with the cell proliferation in malignant pleural mesothelioma
2019 · Akihiro Miura, Hiromasa Yamamoto, et al. · Experimental and Molecular Therapeutics
Abstract 1410: Clinicopathological characteristics of lung cancer patients with concomitant idiopathic pulmonary fibrosis
2019 · Kota Araki, Kazuhiko Shien, et al. · Cancer Research
Additional file 2: of Application of amplicon-based targeted sequencing with the molecular barcoding system to detect uncommon minor EGFR mutations in patients with treatment-naïve lung adenocarcinoma
2019 · Namba, Kei, Tomida, Shuta, et al. · Figshare
Works count: 45
Citation count: 367
H-index: 9
I10-index: 9
Year
Topic
Type